Antibody

Antibody

Home - Uncategorized - BCL2 Antibody – Inducing Apoptosis

BCL2 Antibody – Inducing Apoptosis

Posted on March 28, 2018 in Uncategorized

Bcl2 antibody – The Bcl2 gene plays an important role in a large assortment of cellular activities, in particular the regulation of cell death. This is facilitated by including or repressing apoptosis based on environmental stimuli.

Bcl2 plays an important role in the regulation of cell death, either inducing or repressing apoptosis based on environmental effects. Consequently, because of the apoptotic regulation, Bcl2 plays an important role in cancer research, cancer diagnostics and regulation of immune cells. BCL2 gene damage has been identified as a cause of a number of cancers, including melanoma, breast cancer, prostate cancer, lung cancer and certain types of leukemia.

A damaged BCL2 gene is also the cause of resistance to a number of cancer treatments. Therefore, Bcl2 antibody can be used in immunohistochemistry to distinguish cells that contain the target Bcl2 antigen. The antibodies usually react inside healthy tissues with B cells in the mantle zone, in addition to some T cells. In cancer tissues there is a substantial increase in the number of positive cells in follicular lymphoma and several other forms of cancer. On occasions, the presence or absence of Bcl2 staining in biopsies could perhaps be vital for the patient’s prognosis or the probability of a relapse.

The primary function of Bcl2 is to induce apoptosis; it does so by inducing the release of cytochrome c to begin the apoptotic cascade. Therefore, malfunctions in whichever of the Bcl2 gene or in the apoptotic cascade may possibly lead to damaged cells by missing the signal to shut down. Cancer possibly occurs as the result of an imbalance between cell death and cell growth. Anti-apoptotic protein expression and under expression of pro-apoptotic genes can, and often do, result in the lack of cell death that is characteristic of cancer. Apoptosis is very important in immune system regulation, destroying immune cells that recognize self-antigen, possibly aiding in the prevention of harmful autoimmune diseases such as Lupus and Type 1 diabetes.

The Bcl2 antibody can be used in IHC-P (immunohistochemistry) to distinguish cells that contain the target Bcl2 antigen. The antibodies usually react inside healthy tissues with B cells in the mantle zone, in addition to some T cells. Conversely, in cancer tissues there is a substantial increase in the number of positive cells in follicular lymphoma and several other forms of cancer. On occasions, the presence or absence of Bcl2 staining in biopsies could perhaps be vital for the patient’s prognosis or the probability of a relapse.

In a trial experiment the expression of Bcl2 antibody in skeletal muscles could potentially play a role on surviving muscle fibers. As the control muscles was generally positive in the nuclear membrane and cytoplasm in type 2B fibers. This experiment was conducted by using 178 biopsied human pathologic muscles and 10 control muscles by the ABC process.

The antibody can be tested on a range of applications, for instance WB (western blot), IHC-P (immunohistochemistry), and P-ELISA. This is used to test the antibody on a large assortment of model species such as mouse, rat, cow, dog, chicken, pig, and Human.